🇺🇸 FDA
Pipeline program

Avapritinib, Avapritinib, Avapritinib Placebo Tablets

BLU-285-2203

Phase 2 small_molecule active

Quick answer

Avapritinib, Avapritinib, Avapritinib Placebo Tablets for Indolent Systemic Mastocytosis (ISM) is a Phase 2 program (small_molecule) at Blueprint Medicines (Netherlands) B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Blueprint Medicines (Netherlands) B.V.
Indication
Indolent Systemic Mastocytosis (ISM)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials